Skip to main content
. Author manuscript; available in PMC: 2018 Sep 26.
Published in final edited form as: J Am Coll Cardiol. 2017 Sep 26;70(13):1601–1615. doi: 10.1016/j.jacc.2017.07.789

Table 3.

AT II Effect on Echocardiographic Assessments and Heart Mass Ratios

Wild-type
TNCKO
Saline Vehicle AT II Saline Vehicle AT II
Number 5 9 5 9
Heart rate, beats/min 440 ± 28 426 ± 36 435 ± 18 449 ± 55
EF, % 66.6 ± 1.9 52 ± 2.5 67.8 ± 1.6 42.8 ± 7.3*
FS, % 36.1 ± 1.5 26.3 ± 1.6 37.1 ± 1 20.9 ± 4*
LVIDd, mm 3.57 ± 0.12 3.96 ± 0.23 3.5 ± 0.28 4.08 ± 0.33*
LVIDs, mm 2.28 ± 0.04 2.92 ± 0.16 2.2 ± 0.18 3.23 ± 0.38*
PWTd, mm 0.6 ± 0.07 0.77 ± 0.03 0.64 ± 0.03 0.85 ± 0.08*
PWTs, mm 0.92 ± 0.07 1.05 ± 0.04 0.88 ± 0.07 1.15 ± 0.09*
HW-BW, mg/g 4.06 ± 0.24 4.78 ± 0.4 4.02 ± 0.21 5.26 ± 0.46*

Values are mean ± SD.

*

Significant difference between TNCKO and wild-type mice.

Significant difference between angiotensin (AT) II treatment and saline control group.

Other abbreviations as in Table 1.